Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atosiban in Late Threatened Preterm Birth
NCT05693688Phase 4Completed
- Sponsor
- University of Amsterdam
- Start
- Dec 2017
- Primary completion
- Feb 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in preterm birth comparing Atosiban with Placebo (2 arms). Primary endpoint: Combined perinatal outcome of severe neonatal morbidity and perinatal mortality. Started Dec 2017; status: completed.
02
Drugs
atosiban
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT05693688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05693688.